STAT+: Pharmalittle: AstraZeneca says its vaccine cuts Covid-19 risk by 70%; U.S. shots will ‘hopefully’ start within three weeks
Good morning. I’m Elizabeth Cooney, filling in for Ed Silverman today as he prepares to…
Category: Pharmalot
STAT+: NIH fails to disclose enough details about drug licensing, watchdog report finds
Amid increasing debate over the cost of prescription drugs, a federal watchdog agency found the…
.jpg)
STAT+: Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share…
STAT+: Pharmalittle: Pfizer asking today for emergency-use status for Covid-19 vaccine; Trump to release drug-pricing rules
And so, another working week will soon draw to a close. Not a moment too…
.jpg)
STAT+: To maintain opioid sales, Purdue was advised to pay rebates to health insurers for each overdose
As Purdue Pharma faced serious challenges to OxyContin sales, the company was advised to consider…
STAT+: Pharmalittle: AstraZeneca Covid-19 vaccine shows promise in elderly; surprise rule will require insurers to estimate out-of-pocket drug costs
Top of the morning to you and a fine one, it is. Blue skies and…
STAT+: House passes a bill to close a loophole in a law that gives drug makers ‘unfair’ monopolies
Seeking to boost competition in the pharmaceutical industry, the House passed a bill that would…
STAT+: Pharmalittle: Pfizer Covid-19 vaccine shows 95% effectiveness; FDA vows to disclose scientific data for EUAs
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this…
STAT+: FDA vows to disclose data used to support emergency drug authorizations
In response to blistering criticism, the Food and Drug Administration committed to publicly disclosing reviews…
STAT+: Pharmalittle: Pfizer launches pilot program to deliver Covid-19 vaccine; Amazon announces new online pharmacy offering
Hello, everyone, and how are you today? We are doing just fine, thank you, now…
STAT Plus: New bill would create a subscription payment model to jumpstart antibiotic development
In a bid to combat antimicrobial resistance, two U.S. lawmakers have introduced a bipartisan bill…
STAT Plus: For the first time, drug makers and PBMs must jointly face an insulin price fixing lawsuit
A federal judge ruled that a Texas county can proceed with a lawsuit accusing several…
STAT Plus: Pharmalittle: Trump still insists a Covid-19 vaccine is ‘weeks away’; Regeneron antibody treatment shows promise
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT Plus: For two decades, the FDA approval process for opioids had numerous shortcomings, study finds
Over more than two decades, the Food and Drug Administration approved opioid painkillers based on…
STAT Plus: Catalyst loses lawsuit accusing the FDA of unfairly approving a rival rare disease drug
In a blow to Catalyst Pharmaceuticals (CPRX), a federal judge dismissed its lawsuit accusing the…
STAT Plus: Pharmalittle: Biden getting more pharma donations than Trump; FDA safety plan not ‘well suited’ for opioids
Good morning, everyone, and nice to be back after an extended weekend break. Nonetheless, time…
STAT Plus: An FDA safety program is failing to stem the opioid crisis — and manufacturers are mostly to blame
A mandated safety program regulators rely on to minimize opioid abuse and misuse is not…
STAT Plus: With a new law, California becomes the first state to pursue its own line of generics
In a groundbreaking move, California adopted a law Monday to allow the state to develop…
STAT Plus: Pharmalittle: Operation Warp Speed is more Army than science; J&J’s Covid-19 vaccine moves forward
Good morning, one and all. Damian Garde here, filling in for Ed Silverman at the…
STAT Plus: Pharmalittle: In political ploy, Trump promises drug coupons to seniors; N.Y. plans its own Covid-19 vaccine reviews
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Not by the numbers: Former Aceto controller is charged with insider trading
File this under ‘What was he thinking?’ After spending nearly 17 years as controller at…
STAT Plus: Pharmalittle: Trump may not approve FDA emergency use guidelines; U.K. starts world’s first Covid-19 challenge trial
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Gilead to pay $97 million for allegedly using a charity to pay kickbacks to Medicare patients
Gilead Sciences (GILD) agreed to pay nearly $97 million to resolve allegations that donations it…
STAT Plus: HHS criticizes Lilly for seeking to curtail discounts for safety-net hospitals
In a stern rebuke, the Department of Health and Human Services has taken Eli Lilly…
STAT Plus: Public funding underwrote much of the development of J&J’s drug for TB, analysis finds
Amid ongoing debate over taxpayer dollars used to generate medicines, a new analysis contends that…
STAT Plus: Pharmalittle: FDA to set new standard for Covid-19 vaccine; J&J starts a one-shot vaccine trial
Hello, everyone, and welcome to the middle of the week. Already, you say? Well, the…
STAT Plus: FDA proposes a ‘modest’ change to a rule for policing off-label marketing
After years of controversy, the Food and Drug Administration has issued a proposed rule to…
STAT Plus: Novartis sells bonds tied to expanding access to medicines in poor countries
In a first-of-its-kind move by a large drug maker, Novartis (NVS) raised approximately $2.1 billion…
STAT Plus: Pharmalittle: Medicare wouldn’t cover emergency-use Covid-19 vaccines; 156 countries join WHO vaccine effort
Top of the morning to you, and a fine one it is. Baby blue skies…
STAT Plus: The world is racing toward Covid-19 drugs. In normal times, it takes years to get new antivirals out the door
Researchers may be racing to develop new Covid-19 treatments, but normally it has taken slightly…
STAT Plus: Senators urge bankruptcy judge to prevent Purdue from paying its CEO a $3.5 million bonus
A group of U.S. senators is urging a bankruptcy judge to prevent Purdue Pharma from…
STAT Plus: Pharmalittle: Azar bars FDA from signing new rules; AstraZeneca reveals Covid-19 vaccine trial protocol
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Roche says its drug helped Covid-19 patients; Trump expected to finalize drug importation plan
And so, another working week will soon draw to a close. Not a moment too…
State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”
Nearly a dozen state treasurers are asking Gilead Sciences (GILD) to lower the price of…
STAT Plus: Pharmalittle: Biden-aligned group releases drug-pricing plan; U.S. to ship Covid-19 vaccines lickety-split
Rise and shine, everyone, another busy day is on the way. Most days are quite…
STAT Plus: The cost of Gilead’s HIV prevention pill thwarted widespread use, study finds
The escalating cost of the only HIV prevention pill may have been a key factor…
STAT Plus: Pharmalittle: Lilly drug helped Covid-19 patients; FDA confirms AstraZeneca vaccine trial is on hold
Top of the morning to you, and a fine one it is. Once again, a…
STAT Plus: Lawmakers demand drug makers stop threatening to end discounts for safety-net hospitals
Dozens of U.S. lawmakers sent sharply worded letters to the Trump administration and the pharmaceutical…
STAT Plus: Court rules New York can collect taxes from drug makers to address opioid crisis
A U.S. appeals court upheld a controversial New York state law to require drug makers…
STAT Plus: FDA warns Sprout for failing to mention risks in radio ad for Addyi
The Food and Drug Administration has admonished Sprout Pharmaceuticals for running a radio ad that…
STAT Plus: Pharmalittle: Gates is ‘dumbfounded’ by U.S. Covid-19 response; WHO urges countries to join COVAX
Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy…
STAT Plus: Pharmalittle: Gilead to pay $21 billion to buy Immunomedics; Trump releases executive order on drug pricing
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: A Pennsylvania lawmaker wants to tie prescription drug prices to what Canada pays
In the latest gambit by a state lawmaker to lower prescription drug costs, a Pennsylvania…
STAT Plus: Pharmalittle: NIH to test blood thinners against Covid-19; AbbVie employees feel pressured to return to work
And so, another working week will soon draw to a close. Not a moment too…
Novartis and Roche are fined $528 million for anti-competitive practices in France
France’s anti-trust regulator fined Roche (RHHBY) and Novartis (NVS) a combined $528 million for conspiring…
STAT Plus: Pharmalittle: AstraZeneca hopes for Covid-19 vaccine results by year-end; fewer Americans trust the CDC
Hello, everyone, and how are you today? We are just fine, thank you. A cool…
STAT Plus: U.S. Postal Service changes continue to slow down deliveries of mail-order prescriptions
When it comes to delivering prescription drugs to Americans, the U.S. Postal Service may as…
STAT Plus: Pharmalittle: AstraZeneca pauses its Covid-19 vaccine trial; FDA sticking with its vaccine approval guidelines
Rise and shine, everyone, another busy day is on the way. Our first clue is…
STAT Plus: Drug and device makers paid teaching hospitals $832 million in 2018, creating potential for conflicts of interest
Amid ongoing concern that drug and device makers may influence medical practice and research, a…
STAT Plus: Pharmalittle: Covid-19 vaccine makers pledge to prioritize safety and efficacy; is Operation Warp Speed working?
Good morning, everyone, and nice to see you again after a long holiday break on…